Most drug development organizations have two basic needs.  The first need is to standardize the reporting and second, to streamline the reporting process. SAS-generated reports are a
key component of most clinical study reports that are included in a regulatory submission.  The reporting of most clinical data is similar from study to study and therefore can be standardized.  This standardization creates an opportunity for SAS macro-driven reporting.  

READ MORE

 

Latest News & Articles

04
Sep2020

Digital Solutions in Drug Development

It is vital that we prepare our workforces with the necessary skillsets to...

23
Jul2020

R Programming in clinical trial data analysis

It is vital that we prepare our workforces with the necessary skillsets to...